Folic Acid
FDA-approved product (injectable, injection), marketed as Folic Acid, Folicet, Folvite and 1 more.
- Registered studies
- 50+
- Lab records
- 3
- Pathogens at ≥40%
- 4 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Acne
- Anemia
- Anemia (phenotype)
- Chronic kidney disease
- Chronic renal failure syndrome
- Depressive disorder
- Folate deficiency
- Iron deficiency anemia
- Major depressive disorder
- Osteoporosis
- Type 2 diabetes mellitus
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Folic acid and derivatives; Other diagnostic agents
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against MRSA, E. coli, K. pneumoniae and M. tuberculosis. It was surfaced computationally for further investigation; it is not an established treatment for these infections.
AI-predicted activity
AI prediction · nothing measured- MRSA43.5% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli87.0% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
- K. pneumoniae47.8% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- M. tuberculosis50.0% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
- E. coli: measured active in 3 of 3 lab records
Show the 3 laboratory records, with sources
Loading records…
“Active” means the measured value reached this project’s laboratory cutoff (10 µM or stronger). A laboratory result does not show an effect in patients.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Folic Acid with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Trimetrexate GlucuronateExisting use: Other agents against amoebiasis and other protozoal diseases88.6% AI-predicted activityagainst E. coliLab records exist17 registered studies
- MethotrexateExisting use: Acute lymphoblastic leukemia, Adenoma, Arthritis and 21 more86.8% AI-predicted activityagainst E. coliLab records exist50+ registered studies
- PralatrexateExisting use: Cancer, Mature T-cell and NK-cell non-Hodgkin lymphoma, Neoplasm and 2 more82.2% AI-predicted activityagainst E. coli44 registered studies
- TriclosanExisting use: Phenol and derivatives, Medicated dressings with antiinfectives81.0% AI-predicted activityagainst E. coliLab records exist50+ registered studies
- Leucovorin CalciumExisting use: Osteosarcoma67.6% AI-predicted activityagainst E. coli50+ registered studies
- LevoleucovorinExisting use: Anemia, Colorectal adenocarcinoma, Colorectal cancer and 3 more67.6% AI-predicted activityagainst E. coli50+ registered studies
- PyrimethamineExisting use: Malaria, Toxoplasmosis64.6% AI-predicted activityagainst E. coliLab records exist50+ registered studies
- Copanlisib DihydrochlorideExisting use: Follicular lymphoma, Neoplasm, Neoplasm of mature B-cells63.5% AI-predicted activityagainst E. coli10 registered studies
- AfamelanotideExisting use: Erythropoietic protoporphyria62.6% AI-predicted activityagainst E. coli23 registered studies
- Rimegepant SulfateExisting use: Migraine disorder61.6% AI-predicted activityagainst E. coli50+ registered studies
- Histrelin AcetateExisting use: Neoplasm, Prostate adenocarcinoma, Prostate cancer61.6% AI-predicted activityagainst E. coli13 registered studies
- Pafolacianine SodiumExisting use: Other diagnostic agents61.4% AI-predicted activityagainst E. coli1 registered study
Registered studies
A registration describes a study; it does not establish a positive result.
Pharmacokinetics and Absolute Bioavailability of Fer-In-Sol and Triferic Administered Orally With Shohl's Solution in Healthy Volunteers
NCT02767128 · start 2016-04
Registered record
- Registry ID
- NCT02767128
- Conditions
- Iron-refractory, Iron-deficiency Anemia (IRIDA)
- Interventions
- Triferic; Fer-In-Sol; Shohl's solution
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2016-04
- Completion
- 2016-04
- Enrolment
- 14
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionIron-refractory, Iron-deficiency Anemia (IRIDA)InterventionTriferic; Fer-In-Sol; Shohl's solutionPhasePhase 1Registry statusCompletedThe Effect on Vascular Reactivity Using the Erythropoeitin Alpha on Incident Peritoneal Dialysis Patients
NCT03286712 · start 2015-10
Registered record
- Registry ID
- NCT03286712
- Conditions
- Chronic Kidney Disease; Anemia; Complication of Peritoneal Dialysis
- Interventions
- Renogen
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2015-10
- Completion
- 2017-05
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic Kidney Disease; Anemia; Complication of Peritoneal DialysisInterventionRenogenPhasePhase 4Registry statusCompletedComparison of Two Nutrition Interventions in Young Children in El Salvador
NCT02567981 · start 2015-09
Registered record
- Registry ID
- NCT02567981
- Conditions
- Micronutrient Deficiency
- Interventions
- 21 micronutrient-fortified supplement; Cereal Fortificado (Fortified Cereal); Ferrous sulphate; Vitamin A
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2015-09
- Completion
- 2020-09
- Enrolment
- 4,577
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionMicronutrient DeficiencyIntervention21 micronutrient-fortified supplement; Cereal Fortificado (Fortified Cereal); Ferrous sulphate; Vitamin APhaseNot applicableRegistry statusUnknownThe Effect of Zinc on Iron Bioavailability From Fortified Extruded Rice Fortified With Ferric Pyrophosphate
NCT02255942 · start 2015-04
Registered record
- Registry ID
- NCT02255942
- Conditions
- Iron Deficiency
- Interventions
- Ferric Pyrophosphate and Zinc Oxide; Ferrous sulfate; Ferric Pyrophosphate and Zinc Sulfate; Ferric Pyrophosphate
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2015-04
- Completion
- 2015-07
- Enrolment
- 20
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionIron DeficiencyInterventionFerric Pyrophosphate and Zinc Oxide; Ferrous sulfate; Ferric Pyrophosphate and Zinc Sulfate; Ferric PyrophosphatePhaseNot applicableRegistry statusCompletedIron Supplement to Improve Iron Status Following Bariatric Surgery
NCT02404012 · start 2014-11
Registered record
- Registry ID
- NCT02404012
- Conditions
- Anemia, Iron Deficiency
- Interventions
- Oral iron supplementation
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2014-11
- Completion
- 2021-12-31
- Enrolment
- 64
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAnemia, Iron DeficiencyInterventionOral iron supplementationPhaseNot applicableRegistry statusCompletedIron Absorption From Iron-enriched Aspergillus Oryzae
NCT03156712 · start 2013-05-29
Registered record
- Registry ID
- NCT03156712
- Conditions
- Iron-deficiency; Absorption; Iron; Anemia, Iron Deficiency; Bioavailability; Serum Iron
- Interventions
- Ferrous sulfate
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2013-05-29
- Completion
- 2014-02-13
- Enrolment
- 17
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionIron-deficiency; Absorption; Iron; Anemia, Iron Deficiency +2 moreInterventionFerrous sulfatePhaseNot applicableRegistry statusCompletedCapsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding
NCT01837030 · start 2013-03
Registered record
- Registry ID
- NCT01837030
- Conditions
- Hemorrhage; Anemia
- Interventions
- Ferrous sulfate; Capsule Endoscopy
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Withdrawn
- Start
- 2013-03
- Completion
- 2013-03
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHemorrhage; AnemiaInterventionFerrous sulfate; Capsule EndoscopyPhaseNot applicableRegistry statusWithdrawnThe Efficacy and Safety of Iron Supplementation
NCT01590134 · start 2012-03
Registered record
- Registry ID
- NCT01590134
- Conditions
- Healthy
- Interventions
- Dietary supplement of iron; Ferrous sulphate
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Unknown
- Start
- 2012-03
- Completion
- 2015-12
- Enrolment
- 18
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHealthyInterventionDietary supplement of iron; Ferrous sulphatePhaseNot applicableRegistry statusUnknownIV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD
NCT01438372 · start 2011-11
Registered record
- Registry ID
- NCT01438372
- Conditions
- Iron Deficiency Anemia; Inflammatory Bowel Disease
- Interventions
- Intravenous iron sucrose; Oral ferrous sulfate
- Study type
- INTERVENTIONAL
- Phase
- Phase 2
- Registry status
- Withdrawn
- Start
- 2011-11
- Completion
- 2012-03
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionIron Deficiency Anemia; Inflammatory Bowel DiseaseInterventionIntravenous iron sucrose; Oral ferrous sulfatePhasePhase 2Registry statusWithdrawnEffect of Vitamin A Supplementation on Iron Metabolic Homeostasis of Preschool Children in Sichuan,China
NCT01355263 · start 2011-07
Registered record
- Registry ID
- NCT01355263
- Conditions
- Iron Metabolic Homeostasis
- Interventions
- iron and vitamin a
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2011-07
- Completion
- 2012-08
- Enrolment
- 450
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionIron Metabolic HomeostasisInterventioniron and vitamin aPhaseNot applicableRegistry statusCompletedEnhancing Treatment of Iron Deficiency and Iron Deficiency Anemia With an Antioxidant, Vitamin E
NCT01700426 · start 2011-06
Registered record
- Registry ID
- NCT01700426
- Conditions
- Iron Deficiency; Iron Deficiency Anemia
- Interventions
- Vitamin E; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 1
- Registry status
- Completed
- Start
- 2011-06
- Completion
- 2013-09
- Enrolment
- 44
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionIron Deficiency; Iron Deficiency AnemiaInterventionVitamin E; PlaceboPhasePhase 1Registry statusCompletedDoes a Daily Iron Tablet Improve Anemia in Cystic Fibrosis
NCT01755455 · start 2011-06
Registered record
- Registry ID
- NCT01755455
- Conditions
- Cystic Fibrosis; Anemia, Iron-Deficiency
- Interventions
- Ferrous sulfate 325mg; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2011-06
- Completion
- 2012-11
- Enrolment
- 22
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCystic Fibrosis; Anemia, Iron-DeficiencyInterventionFerrous sulfate 325mg; PlaceboPhaseNot applicableRegistry statusCompletedDiet and Hereditary Haemorrhagic Telangiectasia
NCT01692015 · start 2011-04
Registered record
- Registry ID
- NCT01692015
- Conditions
- Hereditary Haemorrhagic Telangiectasia (HHT)
- Interventions
- Questionnaire on dietary history; Questionnaire on nosebleed severity; One week food diary generated by weighing foods; Blood tests for full blood count, albumin, and indices of nutritional status
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2011-04
- Completion
- 2016-09
- Enrolment
- 50
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHereditary Haemorrhagic Telangiectasia (HHT)InterventionQuestionnaire on dietary history; Questionnaire on nosebleed severity; One week food diary generated by weighing foods; Blood tests for full blood count, albumin, and indices of nutritional statusPhaseNot applicableRegistry statusCompletedIron Supplementation During Pregnancy and Non-Transferrin-Bound Iron (NTBI)
NCT01264042 · start 2011-01
Registered record
- Registry ID
- NCT01264042
- Conditions
- Pregnancy
- Interventions
- Ferrous Sulfate
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2011-01
- Completion
- 2013-09
- Enrolment
- 30
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionPregnancyInterventionFerrous SulfatePhaseNot applicableRegistry statusCompletedRandomized Trial of Iron Supplementation to Prevent Anemia in Very-low-birth-weight Infants
NCT01224236 · start 2010-07
Registered record
- Registry ID
- NCT01224236
- Conditions
- Anemia
- Interventions
- Iron Supplement; control
- Study type
- INTERVENTIONAL
- Phase
- Phase 2 / Phase 3
- Registry status
- Completed
- Start
- 2010-07
- Completion
- 2012-02
- Enrolment
- 150
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionAnemiaInterventionIron Supplement; controlPhasePhase 2 / Phase 3Registry statusCompleted